Whole cell Pertussis
PUBLIC CONSULTATION:
-
BS2285 WHO Guidelines on management of blood and blood components as essential medicines
pdf, 542kb -
BS2285 Comment Form
doc, 63kb -
BS2280 Labelling information of inactivated Influenza vaccines for use in pregnant women
pdf, 479kb
Proposed addendum to: Annex 3 of WHO Technical Report Series, No. 927 Recommendations for the production and control of influenza vaccine (inactivated) -
BS2280 Comment Form
doc, 50kb -
BS2283 WHO Guidelines on estimation of residual risk of HIV, HBV or HCV infections via cellular blood commponents and plasma
pdf, 730kb -
BS2283 Comment Form
doc, 72kb -
BS2284 WHO Manual for the preparation of secondary reference materials for in vitro diagnostic assays designed for infectious disease nucleic acid or antigen detection: Calibration to WHO International Standards
pdf, 1.05Mb -
BS2284 Comment Form
doc, 72kb -
BS2279 Guidelines on the quality, safety and efficacy of Ebola vaccines
pdf, 1.10Mb -
BS2279 Comment Form
doc, 66kb -
BS2287 Guidelines on Clinical evaluation of vaccines: regulatory expectations
pdf, 818kb -
BS2287 Comment Form
docx, 20kb -
BS2288 Human Challenge Trials: scientific and regulatory considerations
pdf, 307kb -
BS2288 Comment Form
doc, 50kb -
BS2289 Guidelines on regulatory preparedness for licensing human pandemic influenza vaccines in non-vaccine-producing countries
pdf, 876kb -
BS2289 Comment Form
doc, 62kb -
BS2290 Guidelines on evaluation of monoclonal antibodies as similar biotherapeutic products (SBPs)
pdf, 475kb -
BS2290 Comment Form
doc, 43kb -
BS2300 Guidelines for the production, control and regulation of snake antivenom immunoglobulins
pdf, 2.19Mb -
BS2300 Comment Form
doc, 104kb
NEW PUBLICATIONS
UPCOMING EVENTS
- Expert Committee on Biological Standardization (ECBS) 17 - 21 October 2016
Contacts
Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971